Hospira Recalls Bupivacaine Hydrochloride Vials Due to Sterility Concerns
Hospira Inc. is recalling 65,109 vials of Bupivacaine Hydrochloride with Epinephrine due to a potential breach in the aseptic process caused by equipment failure.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, an FDA Class II recall involving a drug with a potential sterility breach (risk of serious infection) falls under the 'Severe' category, as it represents a significant risk of harm even without reported hospitalizations.
Plain-English summary
Hospira Inc. is recalling 65,109 vials of Bupivacaine Hydrochloride 0.5% and Epinephrine 1:200,000 Injection, 50 mL, Multiple-dose Fliptop Vial. The affected product is identified by NDC #0409-9046-01 and includes Lot #32-484-EV and Lot #32-485-EV, both with an expiration date of 2/2015.
The recall was initiated because an equipment failure led to a potential breach in the aseptic process, resulting in a lack of assurance of sterility. The product was distributed nationwide in the United States.
Healthcare providers and patients should stop using the affected vials and contact Hospira Inc. for further instructions or to arrange for a return or replacement of the product.
The recalled product
- Product
- BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE HYDROCHLORIDE)
- Brand
- BUPIVACAINE HYDROCHLORIDE
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injection
- Affected units
- 65,109
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #32-484-EV
- 32-485-EV Exp: 2/2015.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · BUPIVACAINE HYDROCHLORIDE
- HighBupivacaine spinal ampules recalled nationwide over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighBupivacaine Hydrochloride Injection Recalled for Temperature Storage Deviations
FDA (Drugs) · 2022-06-15
- HighBupivacaine Hydrochloride Injection Recalled Due to Manufacturing Temperature Deviations
FDA (Drugs) · 2022-06-15
- SevereBupivacaine and Lidocaine Injection Vials Recalled for Label Mix-Up
FDA (Drugs) · 2021-06-09
- CriticalHospira Recalls Bupivacaine Hydrochloride Vials Due to Particulate Matter
FDA (Drugs) · 2016-12-28
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · sterility breach
See all →- ModerateMedline Kits with Zimmer Biomet Mixing Bowls and Spatulas Recalled
FDA (Devices) · 2026-07-22
- ModerateMedline Kits with Zimmer Biomet Mixing Bowls Recalled for Seal Defects
FDA (Devices) · 2026-07-22
- HighIntracept Access Instruments sterile barrier breach risk
FDA (Devices) · 2026-07-15
- ModerateSterile Tourniquet Hoses recalled for potential sterility breach
FDA (Devices) · 2026-07-08
- ModerateSterile Tourniquet Hoses Recalled Due to Potential Sterility Breach
FDA (Devices) · 2026-07-08